Unique Device Identification. Jay Crowley Senior Advisor for Patient Safety Food and Drug Administration

Similar documents
Niccolo Machiavelli (1523)

Data as the key understanding all the options for business improvement Panel

Florence Nightingale Notes on hospitals (1859, revised 1863)

UDI: From Compliance to Value OMTEC June 2013 Karen Conway

There are risks and costs to a program of action. But they are far less than the long-range risks and costs of comfortable inaction

UDI 101: What You Need to Know About Unique Device Identifiers

Niccolo Machiavelli (1523)

The UDI Experience: From a US Perspective

Moving UDI from Regulation to Value Within Hospitals and Beyond

UDI: The Ins and Outs of Global Compliance and Value

Incorporating the Unique Device Identifier (UDI) into Health Care Delivery. Margaret Weiker, President, The Weiker Group

Unique Device Identifier (UDI) Labeling

GS1 Guide on Unique Device Identification (UDI) implementation

Andrea Mitchell. Medtronic

University Health Network UDI Capture Work Group Case Study

UNIQUE DEVICE IDENTIFICATION U.S. FDA. March 2014

Healthcare. Frequently Asked Questions (FAQs) by the Pharmaceutical Industry in Preparing for the U.S. DSCSA

Saudi Drug Code (SDC), and Drug Barcoding Specifications

UDI in the US. Ms. Terrie Reed, Senior Advisor for UDI Adoption U.S. Food and Drug Administration. 19 October 2017

IMPLEMENTATION REALITY SESSION Unique Device Identification (UDI)

The world of GS1 standards in healthcare. Chris Adcock GS1 Global Office

Announcement of Intention to Implement Global Standards for Product Identification, Labeling, and Data Exchange MAY 15, 2017

UDI (Unique Device Identification) and patient safety latest regulatory developments

SE09. Track & Trace Solutions Jeff Bredemus Werner Electric

St. James s Hospital leading global innovation in healthcare - a hospital wide approach to adopting GS1 standards

FDA Unique Device Identification (UDI) System. Readiness and Beyond

LUC UOU Examples Talk Track

FDA Experience with the Sentinel Common Data Model: Addressing Data Sufficiency

MJ Wylie, Johnson & Johnson Nick Manzo, 1WorldSync

Collaboration: GS1 and Joint Initiative Council (JIC) in Healthcare

Global Identification Numbers of the GS1 System

Pfizer s Pedigree & RFID Pilots An Overview

Direct Marking for UDI Compliance. Microscan Systems Inc.

Global GS1 Healthcare Conference Lisbon, October 2012

PHARMA CONGRESS. Pharmacovigilance and Drug Safety: Assessing Future Regulatory and Compliance Developments. October 28, 2008

Serialization and epedigree: New Opportunities for Life Sciences Manufacturers

Pharmaceutical traceability in Brazil

BIOVIGILANCE IN THE UNITED STATES: Regulatory Perspective

Dr. Nazeeh S. Alothmany Meshal A. Al-Amri. Saudi Food & Drug Authority

Verification of Pharmaceutical Products at the Point of Dispense. An EFPIA update

Overcome inventory management challenges with our comprehensive suite of solutions

Clinical Integration Track: It s All About the Data

IHE Pharmacy Technical Framework Supplement. Uniform Barcode Processing (UBP) Rev. 1.0 Draft for Public Comment

Drug Supply Chain Security Act Implementation Track and Trace Issues in 2017

GS1 Healthcare - Discussion paper on multi-market packs for pharmaceutical products

FDA s Center for Devices and Radiological Health: Strategic Priorities for 2017 and Beyond

Utilization of UDI during the Product Recall. 18 September 2015 Terumo Cardiovascular Group Eileen Dorsey

IMPLEMENTAÇÃO DA DIRETIVA DOS MEDICAMENTOS FALSIFICADOS E ATOS DELEGADOS. Pedro Ferreira ANF

Health Care/Pharmaceutical. GS1 Standards for Serialization and Visibility Within the U.S. Pharmaceutical Supply Chain

GS1 Turkey Yeliz Geriş. İTS -Turkish Pharmaceutical Track and Trace System

Guidelines for Bar Coding in the Pharmaceutical Supply Chain

Presentation of Capabilities Reverse Logistics

FOR IMMEDIATE RELEASE

Topics. Safety First Initiative. Drug Safety Communications DRUG SAFETY INITIATIVES AT THE FOOD AND DRUG ADMINISTRATION

Overview of the Drug Supply Chain Security Act. GPhA Fall Technical Conference Bethesda, MD October 28, 2014

Barcodes on Unit of Use

Software Recalls Issues and Challenges

2016 WHITE PAPER. Healthcare Supply Chain Imperatives

Maximiliano Derecho. National Administration of Drugs, Food and Medical Devices (ANMAT), Argentina

Section 2.7: Numbering and Symbol Marking for Very Small

B.Braun: Global Regulatory Compliance Achieves Additional Benefits

Information Management FAQ for UDI

EHR AND ERP INTEGRATION. January 25, 2018

Advance Topics in Pharmacoepidemiology. Risk Management. Conflict of Interest Declaration. Benefit Harm Profile?

KyoungjaLee. Korea Pharmaceutical Information Service (KPIS), Korea

A global view from the Pharmaceutical Industry Mathieu Aman F. Hoffmann-La Roche Ltd, Basel (Switzerland)

Two-Dimensional (2D) Vaccine Barcode Pilot Project

Automated English Translation of Brazil RDC using Google Translate NATIONAL HEALTH SURVEILLANCE AGENCY

Top 15 Questions and Answers. EU FMD Safety Features and Verification

Health systems and products Medical products quality, safety and innovation VERSION 8

Re: Docket No. FDA-2000-D-0067: Medical Device Patient Labeling; Request for Comments; Public Workshop

Are Your Labels Compliant with European MDR? Presenters: Jay Crowley, USDM Ken Moir, NiceLabel Felix Klebe, Microscan Systems Date: October 11, 2017

GUIDANCE ON IMPLEMENTATION OF IDENTIFICATION AND BARCODING OF MEDICINAL PRODUCTS FOR HUMAN USE

Surveillance and Medical Devices

Pharmaceutical RFID: From Mandates to Endorsements and Laws

Unique Device Identification (UDI)

Ensure barcode and printed text quality with machine vision verification

Recommendations on Medical Device and IVD Field Safety Corrective Actions and Recalls using Unique Device Identifiers & GS1 Standards

Source to consumer. Using GS1 standards in retail

Recast Medical Device directives Impacts on materiovigilance

Developments in Operational Procurement Efficiency. Sarah Griffiths Pharmacy Procurement Lead July 2017

ASK THE EXPERTS GS1 DataMatrix

useit in Cath Lab & IR

Oktober 4, 2011 Els C.M. van der Wilden-van Lier, MD, MPH Board of Governors / CMO ZGT. GS1 in Dutch Hospitals

OPDP Update on Oversight of Prescription Drug Promotion

REGULATORY LABELLING REQUIREMENTS AND ITS COMPARISON IN USA AND CANADA

The webinar will begin shortly

Copyright. Jeremiah J. Kelly (2015). All rights reserved. Further dissemination without express written consent strictly prohibited.

Live Demonstration The Auto ID Technologies & In-House Systems for UDI Compliance Brought to you by the AIM North America Healthcare Committee

Benefits of RFID for Medical Device OEMs A PRACTICAL GUIDE

GS1 Ireland Healthcare User Group (HUG) Information Day

GS1 Ireland Healthcare User Group (HUG) Information Day

Harmonizing FDA Regulation and the Practice of Pharmacy: Challenges and Opportunities. Plus an update on PET Drug User Fees

HDA Qs and As on the Drug Supply Chain Security Act (DSCSA) VERSION 4.0 June 2016

LIFE SCIENCES INDUSTRY VISION: LABORATORY AUTOMATION THROUGH A SMART INVENTORY MANAGEMENT SYSTEM

WHITE PAPER UDI: It s Not About (Just) the Barcode

Update on Real World Evidence Data Collection

THE NEW FOOD AND DRUG ADMINISTRATION (FDA) OF THE REPUBLIC OF THE PHILIPPINES

Transcription:

Unique Device Identification Jay Crowley Senior Advisor for Patient Safety Food and Drug Administration jay.crowley@fda.hhs.gov 301-980-1936

Visibility of Device Identification Manufacturer Medical Device Distributor Direct Medical Device Hospital Medical Device Clinical Use Medical Device Unit Medical Device

Device Information Lifecycle Manufacturer Reuse Reorder Reimbursement EHR Device X Lot Y Exp Date Z Clinical Use Registries GPOs Distributor Recall Direct Reduce Medical Error Sales Rep AE Reporting Availability Clinical Substitution Hospital Unit Population Databases Rentals Sold Off-master purchase Hoarding Postmarket Surveillance Anticounterfeit Emergency Preparedness Cost Effectiveness Supply Chain Efficiency Shortage/ Substitution

National Drug Code (NDC) Developed to identify drugs for reimbursement Identifies the manufacturer, product and package size FDA took over in 1972 (The Drug Listing Act) Pharmaceutical barcode rule NDC in linear barcode Ubiquitous use has facilitated Analysis of claims in a large database Retrospective chart review Drug interaction checking and decision support Identifying inappropriate prescribing and dispensing Avoiding confusion with look/sound-alike drugs Reporting adverse events 4

Current Device Identification Non-standard device identification systems; standards used in different ways Not necessary unique or unambiguous Does not include all necessary levels of uniqueness Manufacturers own number/catalogue number Distributors apply different, proprietary number; lot or serial number not captured Hospital yet different identification number/code Information on use not usually captured Control numbers rarely captured 5

Medical Device Identification Develop a system to identify medical devices, which is: Consistent Unambiguous Standardized Differentiates along all identification dimensions Unique at all levels of packaging Harmonized internationally 6

UDI as Foundational Element Patient Safety Benefits Public Health Develop and Implement Various Systems and Processes Consistent and Unambiguous Unique Device Identification Carried throughout Lifecycle 7

UDI Can Improve Medical device recalls Adverse event reporting and postmarket surveillance Tracking and tracing, supply chain security; and anticounterfeiting/diversion Disaster/terror preparation and shortages/substitutions Systems to reduce medical errors Assisting clinicians in identifying appropriate device Documenting medical device use in patient s EHR/PHR, hospital information systems, claims data Sentinel Initiative - strengthening FDA s ability to query data systems for relevant device information 8

FDA Amendments Act of 2007 September 27, 2007, the FDAAA signed into law: The Secretary shall promulgate regulations establishing a unique device identification system for medical devices requiring the label of devices to bear a unique identifier, unless the Secretary requires an alternative placement or provides an exception for a particular device or type of device. The unique identifier shall adequately identify the device through distribution and use, and may include information on the lot or serial number. 9

FDA Amendments Act of 2007 Establish a unique device identification system: Requires that the label of devices bear a unique identifier [ Label is defined as a display of written, printed, or graphic matter upon the immediate container of any article. ]; Allows FDA to describe an alternative placement (e.g., on the device itself or its packaging) for a particular device or device type; 10

FDAAA of 2007 (continued) Establish a unique device identification system: Allows FDA to exempt a particular device or type of device from the UDI requirements; The UDI must adequately identify the device through distribution and use; and The UDI includes information on the lot or serial number. 11

Establishing a UDI System Combination of 3 distinct steps: 1. Develop a standardized system to develop the unique device identifiers (UDI) 2. Place the UDI in human readable and/or AutoID on a device, its label, or both 3. Create and maintain the UDI Database 12

1 st Developing the UDI Develop UDI code according to GS1, HIBCC, NDC Created and maintained by the manufacturer Concatenating Device and Production Identifier Device Identifier: [static] Manufacturer, make, model [i.e., each catalogue number] Production Identifier: [dynamic] if currently serialized serial number; if currently identified at the lot, the lot number, and expiration date 13

2 nd UDI Application Applied at all levels of packaging, down to the lowest level (the patient use level or unit of use) Human readable and/or encoded in a form of automatic identification technology Direct Part Marking (DPM) for some devices No specific technology would be identified (technology neutral) Identify a series of standards (linear barcode, 2- dimensional barcode, RFID) 14

UDI Application Example 15

UDI Application Example 16

3 rd UDI Database Minimum Data Set for each Device Identifier: Manufacturer, make/model (catalogue number) Description GMDN/UNSPCS Category/code Control mechanism Packaging level/number of items Country of origin/manufacture Labeled as single use or reusable Sterility Contains known, labeled allergen (e.g., latex) Storage conditions (e.g., needs to be refrigerated) 17

Unique Device Identification www.fda.gov/cdrh/ocd/udi/ Email: cdrhudi@fda.hhs.gov